Omega Therapeutics (NASDAQ:OMGA) just reported results for the first quarter of 2024. Omega Therapeutics reported earnings per share of -36 cents. This was below the analyst estimate for EPS of ...

Omega Therapeutics (NASDAQ:OMGA) just reported results for the second quarter of 2024. Omega Therapeutics reported earnings per share of -30 cents. This was above the analyst estimate for EPS of ...

Omega Therapeutics, Inc. (OMGA) came out with a quarterly loss of $0.30 per share versus the Zacks Consensus Estimate of a loss of $0.29. This compares to loss of $0.40 per share a year ago.

Omega Therapeutics, Inc. (NASDAQ:OMGA – Get Free Report)’s share price dropped 0.9% on Thursday .The stock traded as low as $1.08 and last traded at $1.12. Approximately 156,117 shares changed ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

There are no important events for this country at this time. Select "All" to see top events in other countries or view all events.

Aug. 14, 2024 (GLOBE NEWSWIRE) -- Omega Therapeutics, Inc. (Nasdaq: OMGA) (“Omega”), a biotechnology company pioneering the development of a new class of programmable epigenomic mRNA medicines, today ...